We live in an exciting time for the RNA research community. Throughout the latter half of the 20th century, we believed that RNA’s primary role was to intermediate between DNA and protein. Over the last three decades, those long-held beliefs have been shattered. From ncRNAs to RNAi, from CRISPR to circular RNAs, we have witnessed astonishing discoveries and equally amazing translation of these breakthroughs to therapy. Come and join the discussion as we explore the era of RNA therapeutics during our inaugural conference at the RNA Therapeutics Institute. 

Joint Keynote Speakers

Victor Ambros UMass Chan Medical School

Gary Ruvkun Harvard Medical School

Speakers & Panelists 

Rodolphe Barrangou, North Carolina State University

Lingling Chen, Shanghai Institute of Biochemistry & Cell Biology

Vasant Jadhav, Alnylam Pharmaceuticals

Aurélie Goyenvalle, Université de Versailles Saint Quentin en Yvelines

Rachel Haurwitz, Caribou Biosciences

Scott Johnson, The Medicines Company

Anastasia Khvorova, UMass Chan Medical School

Adrian Krainer, Cold Spring Harbor Labs

Arthur Krieg, Checkmate Pharmaceuticals

Narry Kim, Seoul National University 

Arthur A. Levin, Avidity Biosciences

Craig Mello, UMass Chan Medical School

Melissa Moore, Moderna Therapeutics

Harry Noller, University of California, Santa Cruz

Olivia Rissland, University of Colorado

Marie Wikström Lindholm,  Silence Therapeutics

 Phillip Sharp, Massachusetts Institute of Technology

Joan Steitz, Yale University

Walter Strapps, Intellia Therapeutics, Inc. 

 

Sponsors

 

 

Exhibitors